Does hypertension confer a hypercoagulable state?

被引:44
作者
Lip, GYH [1 ]
Li-Saw-Hee, FL [1 ]
机构
[1] Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England
关键词
hypertension; hypercoagulable; thrombosis;
D O I
10.1097/00004872-199816070-00003
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Although the blood vessels are exposed to high pressures in hypertension, the main complications of hypertension (stroke and myocardial infarction) are paradoxically thrombotic rather than haemorrhagic, In keeping with Virchow's triad, patients with hypertension do demonstrate abnormalities of vessel wall (endothelial dysfunction or damage), blood constituents (abnormal levels of haemostatic factors, platelet activation and fibrinolysis) and blood flow (rheology and flow reserve), suggesting that hypertension does confer a prothrombotic or hypercoagulable state. These abnormalities appear to be related to target organ damage and long-term prognosis and are altered by treatment The observation that satisfactory blood pressure reduction with non-drug intervention and with various classes of antihypertensive drugs does not lead to an equal reduction in heart attacks and strokes may be due in part to unfavourable effects on the hypercoagulable state in hypertension. Antihypertensive agents with particular benefits in reducing this hypercoagulable state would be likely to have additional advantages in reducing the occurrence of stroke and other thromboembolic events, J Hypertens 16:913-916 (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:913 / 916
页数:4
相关论文
共 39 条
  • [1] Von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
    Blann, AD
    Waite, MA
    [J]. CORONARY ARTERY DISEASE, 1996, 7 (02) : 143 - 147
  • [2] Evidence of platelet activation in hypertension
    Blann, AD
    Lip, GYH
    Islim, IF
    Beevers, DG
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (09) : 607 - 609
  • [3] A RELIABLE MARKER OF ENDOTHELIAL-CELL DYSFUNCTION - DOES IT EXIST
    BLANN, AD
    TABERNER, DA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) : 244 - 248
  • [4] Circulating endothelial cell leucocyte adhesion molecules in ischaemic heart disease
    Blann, AD
    Amiral, J
    McCollum, CN
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (02) : 263 - 265
  • [5] BLANN AD, 1993, J HUM HYPERTENS, V7, P107
  • [6] HEMATOCRIT AND THE RISK OF CORONARY HEART-DISEASE - THE HONOLULU-HEART-PROGRAM
    CARTER, C
    MCGEE, D
    REED, D
    YANO, K
    STEMMERMANN, G
    [J]. AMERICAN HEART JOURNAL, 1983, 105 (04) : 674 - 679
  • [7] DING YA, 1994, J HUM HYPERTENS, V8, P137
  • [8] THE RELATIONSHIP BETWEEN BLOOD-VISCOSITY AND BLOOD-PRESSURE IN A RANDOM SAMPLE OF THE POPULATION AGED 55 TO 74 YEARS
    FOWKES, FGR
    LOWE, GDO
    RUMLEY, A
    LENNIE, SE
    SMITH, FB
    DONNAN, PT
    [J]. EUROPEAN HEART JOURNAL, 1993, 14 (05) : 597 - 601
  • [9] CROSS-LINKED FIBRIN DEGRADATION PRODUCTS, PROGRESSION OF PERIPHERAL ARTERIAL-DISEASE, AND RISK OF CORONARY HEART-DISEASE
    FOWKES, FGR
    LOWE, GDO
    HOUSLEY, E
    RATTRAY, A
    RUMLEY, A
    ELTON, RA
    MACGREGOR, IR
    DAWES, J
    [J]. LANCET, 1993, 342 (8863) : 84 - 86
  • [10] CLINICAL PERSPECTIVE ON CELIPROLOL - CARDIOPROTECTIVE POTENTIAL
    FRISHMAN, WH
    [J]. AMERICAN HEART JOURNAL, 1991, 121 (02) : 724 - 729